Application Note: Tumor Necrosis Factor Receptor Type 1 Recombinant Protein has been tested by SDS-PAGE and biological activity and is suitable as a control for polyclonal or monoclonal anti-Tumor Necrosis Factor Receptor Type 1 in immunological assays.
General Disclaimer Note: This product is for research use only and is not intended for therapeutic or diagnostic applications. Please contact a technical service representative for more information. All products of animal origin manufactured by Rockland Immunochemicals are derived from starting materials of North American origin. Collection was performed in United States Department of Agriculture (USDA) inspected facilities and all materials have been inspected and certified to be free of disease and suitable for exportation. All properties listed are typical characteristics and are not specifications. All suggestions and data are offered in good faith but without guarantee as conditions and methods of use of our products are beyond our control. All claims must be made within 30 days following the date of delivery. The prospective user must determine the suitability of our materials before adopting them on a commercial scale. Suggested uses of our products are not recommendations to use our products in violation of any patent or as a license under any patent of Rockland Immunochemicals, Inc. If you require a commercial license to use this material and do not have one, then return this material, unopened to: Rockland Inc., P.O. BOX 5199, Limerick, Pennsylvania, USA.
Other Performance Data: Endotoxin Level: Measured by kinetic LAL analysis and is typically ≤ 1 EU/μg protein. Biologic Activity: The activity is determined by its ability to inhibit the cytolytic effects 0.25 ng/mL TNFα has on mouse L929 cells, in the presence of Actinomycin D, and is typically between 0.045-0.09 ng/mL.
Physical State: Lyophilized
Purity and Specificity: Tumor Necrosis Factor Receptor Type 1 purity was determined to be greater than 97% as determined by analysis by UV-Spectroscopy at 280nm and by reducing and non-reducing SDS-pAGE.
Background: TNF Receptor 1 (TNFR1) is expressed in most tissues and is activated by soluble and membrane-bound TNFα. TNFR1 is known to activate NF-kB and MAPK pathways to induce inflammation, promote apoptotic cell death, inhibit tumorigenesis and inhibit viral replication. The soluble form of recombinant human TNFR1 is a non-glycosylated protein, containing 162 amino acids, with a molecular weight of 18.3 kDa.
Low Endotoxin: Yes
Other: User Optimized
English
Deutsch
